Mineralys Therapeutics, Inc. (MLYS)
29.96
-0.02
(-0.08%)
USD |
NASDAQ |
May 27, 16:00
29.96
0.00 (0.00%)
After-Hours: 18:38
Mineralys Therapeutics EPS Diluted (Quarterly) : -0.4749 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 2.153 |
| Syndax Pharmaceuticals, Inc. | -0.4835 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Immunic, Inc. | -1.081 |
| Cogent Biosciences, Inc. | -0.60 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -39.34M |
| Total Expenses (Quarterly) | 39.34M |
| Enterprise Value | 1.828B |
| Earnings Yield | -6.87% |
| Normalized Earnings Yield | -6.873 |